Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 4
1981 9
1982 9
1983 7
1984 8
1985 14
1986 25
1987 16
1988 32
1989 37
1990 41
1991 49
1992 40
1993 39
1994 47
1995 77
1996 66
1997 68
1998 65
1999 65
2000 68
2001 91
2002 80
2003 64
2004 78
2005 73
2006 80
2007 69
2008 87
2009 99
2010 91
2011 96
2012 78
2013 82
2014 71
2015 76
2016 82
2017 68
2018 62
2019 47
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

2,090 results
Results by year
Filters applied: . Clear all
Page 1
Cathepsin B and L inhibitors: a patent review (2010 - present).
Li YY, Fang J, Ao GZ. Li YY, et al. Expert Opin Ther Pat. 2017 Jun;27(6):643-656. doi: 10.1080/13543776.2017.1272572. Epub 2016 Dec 23. Expert Opin Ther Pat. 2017. PMID: 27998201 Review.
The lysosomal protein cathepsin L is a progranulin protease.
Lee CW, Stankowski JN, Chew J, Cook CN, Lam YW, Almeida S, Carlomagno Y, Lau KF, Prudencio M, Gao FB, Bogyo M, Dickson DW, Petrucelli L. Lee CW, et al. Mol Neurodegener. 2017 Jul 25;12(1):55. doi: 10.1186/s13024-017-0196-6. Mol Neurodegener. 2017. PMID: 28743268 Free PMC article.
Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury.
Cai J, Zhong H, Wu J, Chen RF, Yang H, Al-Abed Y, Li Y, Li X, Jiang W, Montenegro MF, Yuan H, Billiar T, Chen AF. Cai J, et al. Mol Med. 2017 Jun;23:92-100. doi: 10.2119/molmed.2016.00222. Epub 2016 Mar 20. Mol Med. 2017. PMID: 28332696 Free PMC article.
Cathepsin L, target in cancer treatment?
Lankelma JM, Voorend DM, Barwari T, Koetsveld J, Van der Spek AH, De Porto AP, Van Rooijen G, Van Noorden CJ. Lankelma JM, et al. Life Sci. 2010 Feb 13;86(7-8):225-33. doi: 10.1016/j.lfs.2009.11.016. Epub 2009 Nov 30. Life Sci. 2010. PMID: 19958782 Review.
2,090 results
Jump to page
Feedback